"Neuroleptic malignant syndrome" (NMS) derives from the French "syndrome malin des neuroleptiques" and was first described in 1960 by Delay [1] and colleagues in association with haloperidol.

Since the severe, life-threatening forms of catatonia are infrequent, this book will serve as an excellent source for consultation when faced with neuroleptic malignant syndrome, delirious mania, ...

neuroleptic malignant syndrome and hypercatabolic syndrome. This important new series arises from a coordinated programme of the International Programme on Chemical Safety (IPCS) (ILO/UNEP/WHO) and ...

Yet, clinicians treating persons with autism continue to prescribe older neuroleptic agents targeting ... of tardive dyskinesia and neuroleptic malignant syndrome. This article presents a model ...

The antipsychotic and antiemetic drug is available in tablet, capsule, suppository, syrup, and injectable ...

Oliver McGowan died after contracting Neuroleptic Malignant Syndrome in hospital The consultant who gave a teenager anti-psychotic drugs that have been linked to his death said she "might have ...

Family Handout Oliver died in intensive care after contracting the rare condition Neuroleptic Malignant Syndrome Oliver, who was mildly autistic and had epilepsy and learning difficulties ...

Discontinue immediately and treat appropriately if neuroleptic malignant syndrome occurs. Seizure disorder. Bone-marrow depression. Narrow-angle glaucoma. Prostatic hypertrophy. Stenosing peptic ...

neuroleptic malignant syndrome. <6months: not recommended. ≥6months: Severe behavior disorders: 0.25mg/lb IM every 6–8 hrs if needed. Tetanus: 0.25mg/lb IM or IV (see literature) every 6–8 hrs.